Opportunity
My Florida Marketplace #FDLE-SS-2653
FDLE Single Source Procurement of Qiagen Laboratory Implements and Equipment
Posted
May 11, 2026
Respond By
June 03, 2026
Identifier
FDLE-SS-2653
NAICS
423490
The Florida Department of Law Enforcement (FDLE) is seeking to procure laboratory implements and equipment for its crime laboratories statewide through a single source procurement. - Government Buyer: - Florida Department of Law Enforcement (FDLE), Investigations and Forensic Services, Central Purchasing Office - OEM Highlight: - Qiagen LLC is the sole Original Equipment Manufacturer (OEM) and vendor for this procurement - Products/Services Requested: - Laboratory implements and equipment compatible with QIAGEN EZ1 extraction robot, QIASymphony, and QIAgility systems - Supplies and implements specifically validated for use with FDLE's existing QIAGEN instruments - Supports DNA analysis and forensic laboratory operations - Quantities & Scope: - FDLE operates 40 QIAGEN instruments statewide - Multiple orders will be placed throughout the contract term - Unique/Notable Requirements: - Only QIAGEN products are validated and compatible with FDLE's current laboratory systems - Single source justification based on unique compatibility and validation requirements - Estimated Contract Value: - $1,850,000 - Place of Performance/Delivery: - FDLE crime laboratories statewide, with the main contracting office at 2331 Phillips Rd, Tallahassee, FL 32308
Description
This is a statutorily mandated fifteen business day advertisement of an intended single source procurement by the Florida Department of Law Enforcement (FDLE) for Qiagen implements and equipment for FDLE laboratories. The procurement involves laboratory implements compatible with FDLE's validated equipment and procedures, specifically the QIAGEN EZ1 extraction robot and related systems. The estimated contract term is from July 1, 2026, to June 30, 2027, with an estimated dollar amount of $1,850,000. The single source justification is based on the unique compatibility and validation of QIAGEN products with FDLE's existing laboratory instruments.